NuCana Calls for Shareholder Vote on Key Resolutions

Nucana ( (NCNA) ) has shared an update.

NuCana plc announced on March 18, 2025, that it has distributed a notice for a general meeting scheduled for April 7, 2025, where shareholders will vote on several key resolutions. These include the subdivision and redesignation of its ordinary shares, authorization for the board to allot shares, and the adoption of new articles of association. The outcomes of these resolutions are crucial for NuCana’s financial strategies and operational flexibility, as they aim to bolster the company’s ability to finance its ongoing and future plans. The board has emphasized the importance of these resolutions for the company’s success and strongly recommends shareholders vote in favor.

More about Nucana

NuCana plc is a company based in the United Kingdom, operating in the biotechnology industry. The company focuses on developing innovative therapies for cancer treatment, leveraging its proprietary technology to enhance the efficacy of existing chemotherapy drugs.

YTD Price Performance: -33.06%

Average Trading Volume: 113,424

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $2.99M

Learn more about NCNA stock on TipRanks’ Stock Analysis page.